summit trial tirzepatide results Tirzepatide's Prediabetes Triumph Another "Positive" Heart Failure Trial

Endometriosis and other benign tumors also cause increase in serum CA-125

Naldini L, Blmer U, Gallay P, Ory D, Mulligan R, Gage FH et al

This use is not recommended and carries several safety risks , particularly changes in pigment lesions that may mask melanoma

PlexusDx supports both formats with identical precision dosing and personalized guidance

Patients were excluded from the sample if there was no HbA1c value recorded during the pre-index period or if the pre-index HbA1c value was below 7%, as these patients do not meet the criteria for the study

Clinicians should reassess baseline factors and treatment goals during follow-up visits